Allan I Levey is an expert in Neurology at Emory University (United States). As of October 2026, ScienceLeadR ranks Allan I Levey in the top 1% of experts worldwide for Alzheimer Disease, Dementia and Neurocognitive Disorders. Allan I Levey has authored 1,083 publications, the most recent in 2026, and is an investigator in 10 clinical trials. SLR score: 5,348 (community average: 125). How the SLR is computed.

LeadR Profile

Allan I Levey Emory University United States
5 348 ScienceLeadR Reputation 5348
Network Map

Neurology

Subspecialties: Psychiatry - Biochemistry - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026

Source: PubMed

Emory University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1083

Citations

Citations: 123 412 1st author: 21 Last author: 132 Unique author: 7


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Diabetes-Associated Cognitive Impairment: Pathophysiology and Emerging Therapies.
PMID 42860584 — diabetes mellitus, dementia, aging, brain, cognitive dysfunction, dementia, vascular, cognition disorders, therapeutics, nervous system diseases
Ann Clin Transl Neurol20260
Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer's disease.
PMID 42744775 — genes, neurons, alzheimer disease, aging, mediation analysis, psychiatry, gene expression
Transl Psychiatry20260
GWAS of Tau-Neurodegeneration Mismatch Identifies New Risk Loci for Susceptibility to Tau.
PMID 42678350 — central nervous system diseases, pathology, genome, chromosomes
CNS Neurosci Ther20260
Digital clock assessment in South Asian setting: pilot study.
PMID 42598272 — pilot projects, pilots, tablets
NPJ Dement20261
Inhibition of Moesin and CD44 in stem cell-derived neurons affects the pathological genetic signature associated with Alzheimer's disease.
PMID 42583767 — cells, genes, dementia, microscopy, electron, scanning transmission, neurons, alzheimer disease, transcriptome, stem cells, amyloid, gene expression
Alzheimers Dement20260

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 2 5
Phase 3 4
Phase 2/Phase 3 1

By status:

Completed 8
Terminated 2

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 7

Main Topics

Cohort/Consortium Investigators 68

LeadR Networks

Main global connection map